Literature DB >> 10891477

Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions.

K P Knobeloch1, M D Wright, A F Ochsenbein, O Liesenfeld, J Löhler, R M Zinkernagel, I Horak, Z Orinska.   

Abstract

CD37 is a membrane protein of the tetraspanin superfamily, which includes CD9, CD53, CD63, CD81, and CD82. Many of these molecules are expressed on leukocytes and have been implicated in signal transduction, cell-cell interactions, and cellular activation and development. We generated and analyzed mice deficient for CD37. Despite the high expression of CD37 on cells of the immune system, no changes in development and cellular composition of lymphoid organs were observed in mice lacking CD37. Analyses of humoral immune responses revealed a reduced level of immunoglobulin G1 (IgG1) in the sera of nonimmunized mice and an alteration of responses to T-cell-dependent antigens. Antibody responses to model antigen administered in the absence of adjuvant and to viral infections were generally poor in CD37-deficient mice. These poor antibody responses could be overcome by the immunization of antigen together with adjuvant. These results suggest a role for CD37 in T-cell-B-cell interactions which manifests itself under suboptimal costimulatory conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891477      PMCID: PMC85988          DOI: 10.1128/MCB.20.15.5363-5369.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

Review 1.  The ins and outs of the transmembrane 4 superfamily.

Authors:  M D Wright; M G Tomlinson
Journal:  Immunol Today       Date:  1994-12

2.  Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells.

Authors:  S Constant; D Sant'Angelo; T Pasqualini; T Taylor; D Levin; R Flavell; K Bottomly
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

Review 3.  Adjuvants: current status, clinical perspectives and future prospects.

Authors:  F M Audibert; L D Lise
Journal:  Immunol Today       Date:  1993-06

4.  Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins.

Authors:  P Angelisová; I Hilgert; V Horejsí
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 5.  T cell independent antigens.

Authors:  J J Mond; Q Vos; A Lees; C M Snapper
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

6.  Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates.

Authors:  J K Inman
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen.

Authors:  G Freer; C Burkhart; I Ciernik; M F Bachmann; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells.

Authors:  M Hooper; K Hardy; A Handyside; S Hunter; M Monk
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

9.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.

Authors:  T Kawabe; T Naka; K Yoshida; T Tanaka; H Fujiwara; S Suematsu; N Yoshida; T Kishimoto; H Kikutani
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

10.  T cell regulation of IgG subclass antibody production in response to T-independent antigens.

Authors:  P K Mongini; K E Stein; W E Paul
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  42 in total

1.  Characterization of mice lacking the tetraspanin superfamily member CD151.

Authors:  Mark D Wright; Sean M Geary; Stephen Fitter; Gregory W Moseley; Lai-Man Lau; Kuo-Ching Sheng; Vasso Apostolopoulos; Edouard G Stanley; Denise E Jackson; Leonie K Ashman
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.

Authors:  Tsipi Shoham; Ranjani Rajapaksa; Chiung-Chi Kuo; Joseph Haimovich; Shoshana Levy
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function.

Authors:  Jenny Schröder; Renate Lüllmann-Rauch; Nina Himmerkus; Irina Pleines; Bernhard Nieswandt; Zane Orinska; Friedrich Koch-Nolte; Bernd Schröder; Markus Bleich; Paul Saftig
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

4.  AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.

Authors:  Daniel S Pereira; Claudia I Guevara; Liqing Jin; Nathan Mbong; Alla Verlinsky; Ssucheng J Hsu; Hector Aviña; Sher Karki; Joseph D Abad; Peng Yang; Sung-Ju Moon; Faisal Malik; Michael Y Choi; Zili An; Kendall Morrison; Pia M Challita-Eid; Fernando Doñate; Ingrid B J Joseph; Thomas J Kipps; John E Dick; David R Stover
Journal:  Mol Cancer Ther       Date:  2015-05-01       Impact factor: 6.261

5.  The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.

Authors:  Angelique L Rops; Carl G Figdor; Alie van der Schaaf; Wim P Tamboer; Marinka A Bakker; Jo H Berden; Henry B P M Dijkman; Eric J Steenbergen; Johan van der Vlag; Annemiek B van Spriel
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

6.  SMIP-016 in action: CD37 as a death receptor.

Authors:  Lei Jin; John C Cambier
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

7.  Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals.

Authors:  Rosa Lapalombella; Yuh-Ying Yeh; Liwen Wang; Asha Ramanunni; Sarwish Rafiq; Shruti Jha; Justin Staubli; David M Lucas; Rajeswaran Mani; Sarah E M Herman; Amy J Johnson; Arletta Lozanski; Leslie Andritsos; Jeffrey Jones; Joseph M Flynn; Brian Lannutti; Peter Thompson; Paul Algate; Scott Stromatt; David Jarjoura; Xiaokui Mo; Dasheng Wang; Ching-Shih Chen; Gerard Lozanski; Nyla A Heerema; Susheela Tridandapani; Michael A Freitas; Natarajan Muthusamy; John C Byrd
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

8.  The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation.

Authors:  H Kobayashi; O Hosono; S Iwata; H Kawasaki; M Kuwana; H Tanaka; N H Dang; C Morimoto
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity.

Authors:  Annemiek B van Spriel; Mariam Sofi; Kate H Gartlan; Alie van der Schaaf; Ineke Verschueren; Ruurd Torensma; Reinier A P Raymakers; Bruce E Loveland; Mihai G Netea; Gosse J Adema; Mark D Wright; Carl G Figdor
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

10.  THOC5/FMIP, an mRNA export TREX complex protein, is essential for hematopoietic primitive cell survival in vivo.

Authors:  Annalisa Mancini; Susanne C Niemann-Seyde; Rüdiger Pankow; Omar El Bounkari; Sabine Klebba-Färber; Alexandra Koch; Ewa Jaworska; Elaine Spooncer; Achim D Gruber; Anthony D Whetton; Teruko Tamura
Journal:  BMC Biol       Date:  2010-01-05       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.